TitleREFRACTORY ASCITES DUE TO PORTAL HYPERTENSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS SUCCESSFULLY TREATED WITH PERITONEAL DIALYSIS
AuthorsZheng, Danxia
Cheng, Li-Tao
Han, Qing-Feng
Zhao, Wei
Li, Xuan
Wang, Tao
AffiliationPeking Univ, Div Nephrol, Hosp 3, Beijing 100191, Peoples R China.
Peking Univ, Div Radiol, Hosp 3, Beijing 100191, Peoples R China.
KeywordsAutosomal dominant polycystic kidney disease (ADPKD)
ascites
portal hypertension
polycystic kidney disease
polycystic liver
treatment
VENOUS OUTFLOW OBSTRUCTION
LIVER-DISEASE
MANAGEMENT
PATHOPHYSIOLOGY
CIRRHOSIS
Issue Date2010
Publisher国际腹膜透析
CitationPERITONEAL DIALYSIS INTERNATIONAL.2010,30,(2),151-155.
AbstractRefractory ascites is uncommon in autosomal dominant polycystic kidney disease (ADPKD) but it usually makes the patient physically and psychologically handicapped. Two uremic ADPKD patients in our hospital developed refractory ascites after 1 year on hemodialysis. The refractory ascites was due to portal hypertension, which was caused primarily by portal outflow obstruction due to the numerous enlarged cysts in the liver and secondarily by increased portal inflow. We attempted continuous ambulatory peritoneal dialysis (CAPD) to treat the 2 patients and obtained satisfactory results. Not only was the refractory ascites well controlled, but also the portal hypertension disappeared. Based on our experience, we think CAPD could serve as a very effective therapy to treat the refractory ascites of portal hypertension due to polycystic liver in uremic ADPKD patients.
URIhttp://hdl.handle.net/20.500.11897/344856
ISSN0896-8608
DOI10.3747/pdi.2009.00129
IndexedSCI(E)
PubMed
Appears in Collections:第三医院

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.